Bill > HB1997

This bill establishes the Autologous and Direct Allogeneic Blood Transfusion Act, which requires health care facilities to allow patients to use alternative blood transfusion methods to reduce risks associated with traditional blood transfusions. Specifically, the bill defines two types of blood transfusions: autologous blood transfusions (where a patient donates their own blood for their future use) and direct allogeneic blood transfusions (where blood is donated specifically for a designated individual). Under the bill's provisions, patients must notify their health care facility at least 72 hours before a medical procedure if they intend to use either type of transfusion, and for direct allogeneic transfusions, they must provide a list of eligible blood donors. The primary goal of the legislation is to minimize potential risks such as transfusion reactions and infectious disease transmission by giving patients more control over their blood transfusion options. The bill applies to all health care facilities licensed by the Department of Health, including hospitals, clinics, and outpatient centers, and will take effect 60 days after its passage.

Health and Social Services

https://www.palegis.us/legislation/bills/2025/hb1997